In vitro susceptibility testing of Dientamoeba fragilis

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 1, 2012, Pages 487-494

  Nagata, N ^a,b   Marriott, D ^a,b   Harkness, J ^a,b   Ellis, J T ^b,c   Stark, D ^a,b  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^c UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

4 NITROIMIDAZOLE; ANTIFUNGAL AGENT; DIIODOHYDROXYQUIN; DILOXANIDE FUROATE; FURAZOLIDONE; METRONIDAZOLE; NITAZOXANIDE; ORNIDAZOLE; PAROMOMYCIN; RONIDAZOLE; SECNIDAZOLE; TETRACYCLINE; TINIDAZOLE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL FLORA; BACTERIUM ISOLATION; CELL COUNT; CELL GROWTH; CONCENTRATION (PARAMETERS); DIENTAMOEBA; DIENTAMOEBIASIS; GENOTYPE; IN VITRO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

ANTIPROTOZOAL AGENTS; BACTERIAL TYPING TECHNIQUES; CELL COUNT; CELL CULTURE TECHNIQUES; DIENTAMOEBA; DIENTAMOEBIASIS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENOTYPE; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; MICROBIAL SENSITIVITY TESTS; NITROIMIDAZOLES; TROPHOZOITES;

EID: 84455192596     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.05125-11     Document Type: Article

References (37)

1. Abramowicz M. 1995. Drugs for parasitic infections. Med. Lett. Drugs Ther. 37:99-108.
2. Adagu IS, Nolder D, Warhurst DC, Rossignol JF. 2002. In vitro activity of nitazoxanide and related compounds against isolates of Giardia intestinalis, Entamoeba histolytica and Trichomonas vaginalis. J. Antimicrob. Chemother. 49:103-111. (Pubitemid 34100652)
3. Balcioglu IC, et al. 2007. Rural life, lower socioeconomic status and parasitic infections. Parasitol. Int. 56:129-133. (Pubitemid 46357032)
4. Barratt JL, et al. 2010. Newly defined conditions for the in vitro cultivation and cryopreservation of Dientamoeba fragilis: new techniques set to fast track molecular studies on this organism. Parasitology 137:1867-1878.
5. Barratt JLN, Harkness J, Marriott D, Ellis JT, Stark D. 2010. A review of Dientamoeba fragilis carriage in humans: several reasons why this organism should be considered in the diagnosis of gastrointestinal illness. Gut Microbes 2:3-12.
6. Bart A, et al. 2008. Intragenomic variation in the internal transcribed spacer 1 region of Dientamoeba fragilis as a molecular epidemiological marker. J. Clin. Microbiol. 46:3270-3275.
7. Boreham P, Phillips R, Shepherd R. 1985. A comparison of the in-vitro activity of some 5-nitroimidazoles and other compounds against Giardia intestinalis. J. Antimicrob. Chemother. 16:589.
8. Butler WP. 1996. Dientamoeba fragilis. An unusual intestinal pathogen. Dig. Dis. Sci. 41:1811-1813. (Pubitemid 26319758)
9. Cedillo-Rivera R, Chavez B, Gonzalez-Robles A, Tapia A, Yepez-Mulia L. 2002. In vitro effect of nitazoxanide against Entamoeba histolytica, Giardia intestinalis and Trichomonas vaginalis trophozoites. J. Eukaryot. Microbiol. 49:201-208. (Pubitemid 34780639)
10. Chan FT, Guan MX, Mackenzie AM, Diaz-Mitoma F. 1994. Susceptibility testing of Dientamoeba fragilis ATCC 30948 with iodoquinol, paromomycin, tetracycline, and metronidazole. Antimicrob. Agents Chemother. 38:1157-1160. (Pubitemid 24150856)
11. Clark CG. 2000. Cryptic genetic variation in parasitic protozoa. J. Med. Microbiol. 49:489-491. (Pubitemid 30347584)
12. Clark CG, Diamond LS. 2002. Methods for cultivation of luminal parasitic protists of clinical importance. Clin. Microbiol. Rev. 15:329.
13. Cuffari C, Oligny L, Seidman EG. 1998. Dientamoeba fragilis masquerading as allergic colitis. J. Pediatr. Gastroenterol. Nutr. 26:16-20. (Pubitemid 28023830)
14. Fung HB, Doan TL. 2005. Tinidazole: a nitroimidazole antiprotozoal agent. Clin. Ther. 27:1859-1884. (Pubitemid 43293209)
15. Gadkariem EA, Belal F, Abounassif MA, El-Obeid HA, Ibrahim KEE. 2004. Stability studies on diloxanide furoate: effect of pH, temperature, gastric and intestinal fluids. Il Farmaco 59:323-329. (Pubitemid 38471926)
16. Girginkardesler N, Coşkun S, Cüneyt Balcioǧlu I, Ertan P, Ok UZ. 2003. Dientamoeba fragilis, a neglected cause of diarrhea, successfully treated with secnidazole. Clin. Microbiol. Infect. 9:110-113. (Pubitemid 36527054)
17. Girginkardesler N, Kurt O, Kilimcioglu AA, Ok UZ. 2008. Transmission of Dientamoeba fragilis: evaluation of the role of Enterobius vermicularis. Parasitol. Int. 57:72-75. (Pubitemid 350116688)
18. Jepps M, Dobell C. 1918. Dientamoeba fragilis ng, n. sp., a new intestinal amoeba from man. Parasitology 10:352-367.
19. Reference deleted.
20. Kather EJ, Marks SL, Kass PH. 2007. Determination of the in vitro susceptibility of feline Tritrichomonas foetus to 5 antimicrobial agents. J. Vet. Intern. Med. 21:966-970. (Pubitemid 47510780)
21. Kean B, Malloch C. 1966. The neglected ameba: Dientamoeba fragilis. A report of 100 "pure" infections. Am. J. Dig. Dis. 11:735.
22. Khaw M, Panosian CB. 1995. Human antiprotozoal therapy: past, present, and future. Clin. Microbiol. Rev. 8:427-439.
23. Kurt O, Girginkardesler N, Balcioglu IC, Ozbilgin A, Ok UZ. 2008. A comparison of metronidazole and single-dose ornidazole for the treatment of dientamoebiasis. Clin. Microbiol. Infect. 14:601-604. (Pubitemid 351639076)
24. Norberg A, Nord C, Evengård B. 2003. Dientamoeba fragilis - a protozoal infection which may cause severe bowel distress. Clin. Microbiol. Infect. 9:65-68.
25. Peek R, Reedeker FR, van Gool T. 2004. Direct amplification and genotyping of Dientamoeba fragilis from human stool specimens. J. Clin. Microbiol. 42:631-635. (Pubitemid 38222639)
26. Preiss U, Ockert G, Brömme S, Otto A. 1990. Dientamoeba fragilis infection, a cause of gastrointestinal symptoms in childhood. Klin. Padiatr. 202:120-123. (Pubitemid 20097808)
27. .Raether W, Hänel H. 2003. Nitroheterocyclic drugs with broad speetrum activity. Parasitol. Res. 90(Suppl 1):S19-S39. (Pubitemid 36831290)
28. Rossignol JF, Maisonneuve H. 1984. Nitazoxanide in the treatment of Taenia saginata and Hymenolepis nana infections. Am. J. Trop. Med. Hyg. 33:511-512. (Pubitemid 14075656)
29. Reference deleted.
30. Stark D, et al. 2010. A review of the clinical presentation of dientamoebiasis. Am. J. Trop. Med. Hyg. 82:614-619.
31. Stark D, Beebe N, Marriott D, Ellis J, Harkness J. 2005. Detection of Dientamoeba fragilis in fresh stool specimens using PCR. Int. J. Parasitol. 35:57-62. (Pubitemid 41556672)
32. Stark D, Beebe N, Marriott D, Ellis J, Harkness J. 2005. Prospective study of the prevalence, genotyping, and clinical relevance of Dientamoeba fragilis infections in an Australian population. J. Clin. Microbiol. 43:2718-2723. (Pubitemid 40827944)
33. Stark D, van Hal S, Marriott D, Ellis J, Harkness J. 2007. Irritable bowel syndrome: a review on the role of intestinal protozoa and the importance of their detection and diagnosis. Int. J. Parasitol. 37:11-20. (Pubitemid 44958562)
34. Vandenberg O, et al. 2006. Clinical and microbiological features of dientamoebiasis in patients suspected of suffering from a parasitic gastrointestinal illness: a comparison of Dientamoeba fragilis and Giardia lamblia infections. Int. J. Infect. Dis. 10:255-261.
35. Wheeler D, Bhagwat M. 2007. BLAST QuickStart: example-driven web-based BLAST tutorial. Methods Mol. Biol. 395:149-176. (Pubitemid 350183293)
36. Reference deleted.
37. Windsor JJ, Clark CG, Macfarlane L. 2004. Molecular typing of Dientamoeba fragilis. Br. J. Biomed. Sci. 61:153-155. (Pubitemid 39286875)